6 Million Canadians Living with Heart Disease: New 2026 Report
Heart & Stroke report reveals 90% of Canadians have at least one risk factor for heart disease. Learn about the new data on hypertension, diabetes, and vaping.
Your Plants Impact Your Health and Your Pet’s Health
Struggling with dry air and winter blues? Staff your home with the right plants. A room-by-room guide to health, safety, and pet-friendly greenery.
The $37 Billion Blind Spot: Why Canada Needs to Close the Women’s Health Gap
Canadian women spend 24% more time in poor health than men. Discover why this $37B gap exists and how to advocate for the care you deserve.
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
Health Canada Authorizes Nemluvio® for Eczema and Prurigo Nodularis
Health Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
There’s a Reason Your Voice May Not Be As Clear as it Can Be
From dry winters to loud parties, your voice takes a beating. Learn how to protect your "vocal instrument" with these expert tips and SAC guidelines.
Health Canada Authorizes TNKase for Treatment of Adult Stroke
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.
Affordable Dental Care is Here. This is where to find it.
Don't let cost stop you! THI breaks down the Canadian Dental Care Plan (CDCP) and shows you where to find discounted, supervised care near you.
Canada Authorizes First-Ever Oral Treatment for Postpartum Depression
Canada approves ZURZUVAE, the first oral PPD pill. This breakthrough 14-day oral therapy aims to elevate the standard of maternal mental health care.
Optometrist vs. Ophthalmologist: Who to See, When and What Your Province Actually Covers
Stop guessing! This essential guide clarifies the roles of optometrists, ophthalmologists, and opticians, details provincial coverage for you, and sets your eye exam schedule.
No Longer a Smoker’s Disease: Rewriting Canada’s Lung Cancer Narrative
Canada’s new Pan-Canadian Lung Cancer Action Plan aims to cut deaths by 30% by 2035.